Cargando…
How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review
BACKGROUND: Patients with severe vasodilation accompanied by refractory hypotension despite high doses of vasopressors were associated with a high mortality rate. The Ang-2 for the Treatment of High-Output Shock (ATHOS) 3 trial demonstrated that angiotensin 2 (Ang-2) could effectively increase MAP a...
Autores principales: | Semedi, Bambang Pujo, Rehatta, Nancy Margarita, Soetjipto, Soetjipto, Nugraha, Jusak, Mahyuddin, Muhammad H, Arnindita, Jannatin N, Wairooy, Nabilah A P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830054/ https://www.ncbi.nlm.nih.gov/pubmed/36636460 http://dx.doi.org/10.2147/OAEM.S391167 |
Ejemplares similares
-
Antioxidant Role in Critically Ill Patients with Vasodilatory Shock: Does Glutathione Peroxidase Correlate to Severity of Tissue Hypoxia and Organ Failure
por: Semedi, Bambang Pujo, et al.
Publicado: (2023) -
Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017) -
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020) -
Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018) -
The Correlations of Human Atrial Natriuretic Peptide on Cardiac Function and Hemodynamics in Pediatric Septic Shock
por: Setyaningtyas, Arina, et al.
Publicado: (2022)